Evidence for an increase in functional platelet 5-HT(2A) receptors in depressed patients using the new ligand [125I]-DOI

European Psychiatry

Volumn 14, Issue 8, 1999, Pages 451-457

  Serres, F ^a   Azorin, J M ^a   Valli, M ^a   Jeanningros, R ^a  

^a INSERM   (France)

Author keywords

5 HT(2A) receptors; Depression; DOI; Platelet; Serotonin

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; IODINE 125; SEROTONIN 2A RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; SEROTONINERGIC SYSTEM; SUICIDAL BEHAVIOR; THROMBOCYTE;

EID: 0033397715     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(99)00222-9     Document Type: Article

References (46)

1. . Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. 1987;Washington, DC: American Psychiatric Press.
2. Andres A.H., Rao M.L., Ostrowitzki S., Entzian W. Human brain cortex and platelet serotonin-2 receptor binding properties and their regulation by endogenous serotonin. Life Sci. 52:1993;313-321.
3. Arango V., Ernsberger P., Marzuk P.M., Chen J.S., Tierney H., Stanley M., et al. Autoradiographic demonstration of increased serotonin 5-HT2 and β-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry. 47:1990;1038-1047.
4. Arora R.C., Meltzer H.Y. Serotonergic measures in the brains of suicide victims: 5HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry. 146:1989;730-736.
5. Arora R.C., Meltzer H.Y. Increased serotonin-2 (5-HT2) receptor binding as measured by [3H]-lysergic acid diethylamine ([3H]-LSD) in the blood platelets of depressed patients. Life Sci. 44:1989;725-734.
6. Asberg M. Monoamine neurotransmitters in human aggressiveness and violence: a selective review. Crim Behav Ment Health. 4:1994;303-327.
7. Battaglia G., Shannon M., Titeler M. Guanyl nucleotide and divalent cation regulation of cortical S2 serotonin receptors. J Neurochem. 43:1994;1213-1219.
8. Biegon A., Weizman A., Karp L., Ram A., Tiano S., Wolff M. Serotonin 5-HT2 receptor binding on blood platelets : A peripheral marker for depression? Life Sci. 41:1987;2485-2492.
9. Biegon A., Essar N., Israeli M., Elizur A., Bruch S., Bar-Nathan A.A. Serotonin 5HT2 receptor binding on blood platelets as a state dependent marker in major affective disorder. Psychopharmacology. 102:1990;73-75.
10. Biegon A., Grinspoon A., Blumenfeld B., Bleich A., Apter A., Mester R. Increased serotonin 5-HT2 receptor binding on blood platelet of suicidal men. Psychopharmacology. 100:1990;165-167.
11. Biegon A., Greuner N. Age-related changes in serotonin 5HT2 receptors on human blood platelets. Psychopharmacology. 108:1992;210-212.
12. Chatterjee D., Anderson G.M., Chakraborty M., Cohen D.J. Human platelet dense granules : improved isolation and preliminary characterization of [3H]-serotonin uptake and tetrabenazine displaceable [3H]-ketanserin binding. Life Sci. 46:1990;1755-1764.
13. Conn P.J., Sanders-Bush E. Serotonin-stimulated phosphoinositide turnover : mediation by the S2 binding site in rat cerebral cortex but not in subcortical region. J Pharmacol Exp Ther. 234:1985;195-203.
14. Cook E.H. Jr, Fletcher K.E., Wainwright M., Marks N., Yan S., Leventhal L. Primary structure of the human platelet serotonin 5-HT2A receptor: Identity with frontal cortex serotonin 5-HT2A receptor. J Neurochem. 63:1994;465-469.
15. Cowen P.J., Charig E.M., Fraser S., Elliott J.M. Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment. J Affect Dis. 13:1987;45-50.
16. De Chaffoy D.E., Courcelles D., Leysen J.E., De Clerk F., VanBelle H., Janssen P.A.J. Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites. J Biochem Chem. 206:1985;7603-7608.
17. Declerk F., David J.L., Janssen P.A. Inhibition of 5-hydroxytryptamine-induced and amplified-aggregation by ketanserin (R41468), a selective 5-HT2 receptor antagonist. Agents Actions. 12:1982;388-397.
18. Elliott J.M., Kent A. Comparison of [125I]iodolysergic acid diethylamine binding in human frontal cortex and platelet tissue. J Neurochem. 53:1989;191-196.
19. Endicott J., Spitzer R.L. Use of the research diagnostic criteria and the schedule for affective disorders and schizophrenia to study affective Disorders. Am J Psychiatry. 136:1979;52-56.
20. Fink G., Sumner B.E.H., Rosie R., Grace O., Quinn J.P. Estrogen control of central neurotransmission: Effect on mood, mental state, and memory. Cell Mol Neurobiol. 16:1996;325-343.
21. Geaney D.P., Schachter M., Elliott J.M., Grahame-Smith D.G. Characterization of [3H]-lysergic acid diethylamine binding to a 5-hydroxytryptamine receptor on human platelet membranes. Eur J Pharmacol. 97:1984;87-93.
22. Glennon R.A., Seggel M., Soine W.H., David K.H., Lyon R.A., Titeler M. [125I]-DOI: an iodinated radioligand that specifically labels the agonist high affinity state of the 5-HT2 receptor. J Med Chem. 31:1988;5-7.
23. Grahame-Smith D.G., Geaney D.P., Schachter M., Elliott J.M. Human platelet 5-hydroxytryptamine receptors: Binding of [3H]-lysergic acid dyethylamide (LSD). Experientia. 44:1988;142-145.
24. Hamilton M. Development of rating scale for primary depressive illness. Br J Soc Clin Psychol. 6:1967;278-296.
25. Himeno A., Saavedra J.M. Human platelet [125I]-DOI binding sites: characterization by in vitro autoradiography. Neuropsychopharmacol. 3:1990;25-32.
26. Hrdina P.D., Demeter E., Vu T.B., Sonotyi P., Palkovits M. HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5HT2 sites in cortex and amygdala. Brain Res. 614:1993;37-44.
27. Hrdina P.D., Bakish D., Chudzik J., Ravindran A., Lapierre Y.D. Serotonergic markers in platelets of patients with major depression : Upregulation of 5HT2 receptors. J Psychiatry Neurosci. 20:1995;11-19.
28. Kayaga A., Mikuni M., Takahashi K. Modulation of 5HT2 receptor-mediated intracellular calcium movement in platelets and its function in affective disorders. Jpn J Psychiatry Neurol. 45:1991;117-118.
29. Kusumi I., Koyama T., Yamashita I. Serotonin-stimulated Ca2+ response is increased in the blood platelets of depressed patients. Biol Psychiatry. 30:1991;310-312.
30. Leysen J.E., De Chaffoy D.E., Courcelles D., De Clerk F., Niemegers C.J.E., VanNeuten J.M. Serotonin receptor binding sites and functional correlates. Neuropharmacology. 23:1984;1493-1501.
31. Leysen J.E., Gommeren W., Janssen A.J. Identification of non-serotonergic [3H]-ketanserin binding sites on human platelets and their role in serotonin release. Eur J Pharmacol. 206:1991;39-45.
32. Mann J.J., Stanley M., Mc Bride P.A., McEwen B.S. Increased serotonin-2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psych. 43:1986;954-959.
33. McBride P.A., Brown R.P., Demeo M., Keilp J., Mieczkowski T., Mann J.J. The relationship of platelet 5HT2 receptor indices to major depressive disorder, personality traits, and suicidal behavior. Biol Psychiatry. 35:1994;295-308.
34. McClue S.J., Brazell C., Stahl S.M. Hallucinogenic drugs are partial agonists of the human platelet shape change response: a physiological model of the 5-HT2 receptor. Biol Psychiatry. 26:1989;297-302.
35. McKeith I.G., Marschall E.F., Ferrier I.N., Armstrong M.M., Kennedy W.N., Perry R.H. 5-HT receptor binding in post-mortem brain from patients with affective disorder. J Affect Dis. 13:1987;67-74.
36. Mikuni M., Kusumi I., Kayaga A., Kuroda Y., Mori H., Takajashi K. Increased 5-HT2 receptor function as measured by serotonin-stimulated phophoinositide hydrolysis in platelets of depressed patients. Prog Neuro-Psychopharmacol Biol Psychiat. 15:1991;49-51.
37. Munson M., Rodbard R. LIGAND: A versatile computerized approach for the characterization of ligand binding systems. Anal Biochem. 107:1980;220-239.
38. Oliva D., Pocchiari F., Allievi L., Rovati G.E., Nicosia S. Non-serotonergic [3H]-ketanserin binding sites in human platelets: Characteristics and interaction with calcium antagonists. Pharmacol Res. 26:1992;187-199.
39. Pandey G.N., Pandey S.C., Janicak P.G., Marks R.C., Davis J.M. Platelet serotonin-2 receptor binding sites in depression and suicide. Biol Psychiatry. 28:1990;215-222.
40. Pandey G.N., Pandey S.C., Dwivedi Y., Sharma R.P., Janicak P.G., Davis J.M. Platelet serotonin-2A receptors : a potential biological marker for suicidal behavior. Am J Psychiatry. 152:1995;850-855.
41. Pandey S.C., Sharma R.P., Janicak P.G., Marks R.C., Davis J.M., Pandey G.N. Platelet serotonin-2 receptors in schizophrenia : effects of illness and neuroleptic treatment. Psychiatry Res. 48:1993;57-68.
42. Peterson G.L. A simplification of the protein assay method of Lowry et al which is more generally applicable. Anal Biochem. 83:1977;346-348.
43. Pierce P.A., Peroutka S.J. Ring-substituted amphetamine interactions with neurotransmitters receptor binding sites in human cortex. Neurosci Lett. 95:1988;208-212.
44. Steckler T., Ruggeberg-Schmidt K., Muller-Oerlinghausen B. Human platelet 5-HT2 receptor binding sites reevaluated : a criticism of recurrent techniques. J Neural Transm Gen Sect. 92:1993;11-24.
45. Teitler M., Leonhardt S., Weisberg E.L., Hoffman B.J. [125I]iodo-92, 5-dimethoxy) phenylisopropylamine and [3H]-ketanserin labelling of 5-hydroxytryptamine 2 (5HT2) receptors in mammalian cells transfected with a rat cDNA: evidence for multiple state and not for multiple 5HT2 receptor subtypes. Mol Pharmacol. 38:1990;594-598.
46. Yates M., Leake A., Candy J.M., Fairbain A.F., McKeith I.G., Ferrier I.N. 5-HT2 receptor changes in major depression. Biol Psychiatry. 27:1990;489-496.